A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young(The University of Queensland), Mark J. Smyth(Peter MacCallum Cancer Centre), Deborah S. Barkauskas(QIMR Berghofer Medical Research Institute), Éric Vivier(Innate Pharma (France)), Joel Linden(University of Virginia), Yulong Gao(The University of Queensland), Fernando Souza-Fonseca-Guimarães(The University of Queensland), Ann‐Marie Patch(QIMR Berghofer Medical Research Institute), Mariapia A. Degli‐Esposti(Lions Eye Institute), Gene Lin(La Jolla Institute for Immunology), Meriem Messaoudene(Centre Hospitalier de l’Université de Montréal), Shin Foong Ngiow(Parker Institute for Cancer Immunotherapy), Jérôme D. Coudert(The University of Western Australia), Laurence Zitvogel(Institut Gustave Roussy), Nicola Waddell(QIMR Berghofer Medical Research Institute), Nicholas D. Huntington(The University of Melbourne), Kimberley Stannard(QIMR Berghofer Medical Research Institute)
Cited by 378
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Functions of natural killer cells
|Nature Immunology|2008|3.8k
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Immune surveillance of tumors
|Journal of Clinical Investigation|2007|1.4k